Contrarius Investment Management Ltd lowered its stake in shares of bluebird bio, Inc. (NASDAQ:BLUE – Free Report) by 7.8% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,206,506 shares of the biotechnology company’s stock after selling 101,496 shares during the period. […]